The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

The EACR’s Top 10 Cancer Research Publications: February 2022

October 17, 2025
EACR top 10 cancer research publications

The EACR’s Top 10 Cancer Research Publications is a regular summary of the most interesting and impactful recent papers in cancer research. It is curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

4. Dietary palmitic acid promotes a prometastatic memory via Schwann cells

  • 1. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
  • 2. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
  • 3. Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, BRAF-mutated Urothelial Carcinoma
  • 4. Dietary palmitic acid promotes a prometastatic memory via Schwann cells
  • 5. Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
  • 6. Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
  • 7. Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer
  • 8. Multi-omic machine learning predictor of breast cancer therapy response
  • 9. Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death
  • 10. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Previous
Next

Pascual, G., Domínguez, D., Elosúa-Bayes, M. et al. Nature 599, 485–490 (2021).

Summary of the findings

Fatty acid uptake and an altered metabolism are hallmarks of metastasis. In this work, we describe how dietary palmitic acid (and not oleic or linoleic acids) induces a more aggressive profile in tumour cells and how this remains as a form of cellular “memory”. Tumours from mice fed a short-term diet rich in palm oil and tumour cells
briefly exposed to palmitic acid in vitro remained highly metastatic even after being
successively transplanted (without further exposure to high levels of this fatty acid).

The prometastatic profile is related to the capacity of the tumour cells to establish a neural network around the tumour. The palmitic acid-induced prometastatic memory, which is dependent on the fatty acid transporter CD36, the transcription factor EGR2 and the glial-cell-stimulating peptide galanin, promotes a pro-regenerative state of tumour-activated Schwann cells, which secrete a specialized extracellular matrix. Intratumoural Schwann cells and innervation are parameters that strongly correlate with metastasis.

Using a variety of approaches to block the formation of the neural network surrounding the tumour, we were able to prevent the development of metastases.

Future impact of the findings

Our findings provide a novel insight into the metastasis initiation process and may drive new approaches to tackle cancer. In this regard, the mechanisms detailed in our work pave the way for the development of therapies that specifically block metastasis, which is the main cause of death by cancer.

Read more in Nature

4. Dietary palmitic acid promotes a prometastatic memory via Schwann cells

  • 1. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
  • 2. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
  • 3. Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, BRAF-mutated Urothelial Carcinoma
  • 4. Dietary palmitic acid promotes a prometastatic memory via Schwann cells
  • 5. Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
  • 6. Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
  • 7. Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer
  • 8. Multi-omic machine learning predictor of breast cancer therapy response
  • 9. Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death
  • 10. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Previous
Next
Tags: EACR Top Ten Cancer Research Publications

Related Posts

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026

The EACR, AACR, and The Mark Foundation for Cancer Research recently teamed up to offer a number of travel grants to help EACR or AACR members...

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026

https://www.youtube.com/watch?v=KdMqmIIgNYo Click above to watch On 9 April 2026, the EACR hosted a free webinar bringing together leading experts to explore the Cancer Genome Interpreter (CGI)...

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

April 13, 2026

What does it take to bridge the gap between researchers and patients? In this episode, scientists, oncologists, and patient advocates from Canada, the United States, and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities
Community

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026
VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter
Features

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR